AbCellera Biologics Inc. ABCL Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance.
The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent?
- AbCellera Biologics Inc. (ABCL) reported effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent of -6.9% in Q4 2025.
- What does effective income tax rate reconciliation, change in deferred tax assets valuation allowance, percent mean?
- Expresses the change in the valuation allowance for deferred tax assets as a percentage impact on the effective income tax rate. This metric helps investors evaluate how changes in the recoverability of tax assets influence the company's reported tax rate.